DOCSLIB.ORG

Chapter 4.0 Page 4.1 400 Pci/L (EPA 1985), Which Corresponds to About 0.2 to 1 Dpm/Ml

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chapter 4.0 Page 4.1 400 Pci/L (EPA 1985), Which Corresponds to About 0.2 to 1 Dpm/Ml PNNL-15614 Methods and Models of the Hanford Internal Dosimetry Program PNNL-MA-860 E. H. Carbaugh D. E. Bihl J. A. MacLellan January 1, 2003 Prepared for the U.S. Department of Energy under Contract DE-AC06-76RL01830 DISCLAIMER This report was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor Battelle Memorial Institute, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof, or Battelle Memorial Institute. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. PACIFIC NORTHWEST NATIONAL LABORATORY operated by BATTELLE for the UNITED STATES DEPARTMENT OF ENERGY under Contract DE-AC06-76RL01830 Printed in the United States of America Available to DOE and DOE contractors from the Office of Scientific and Technical Information, P.O. Box 62, Oak Ridge, TN 37831-0062; ph: (865) 576-8401 fax: (865) 576-5728 email: [email protected] Available to the public from the National Technical Information Service, U.S. Department of Commerce, 5285 Port Royal Rd., Springfield, VA 22161 ph: (800) 553-6847 fax: (703) 605-6900 email: [email protected] online ordering: http://www.ntis.gov/ordering.htm This document was printed on recycled paper. (8/00) PNNL-MA-860 Radiation and Health Technology Methods and Models of the Hanford Internal Dosimetry Program, PNNL-MA-860 Approved for Use and Application by: Pacific Northwest National Laboratory Richland, Washington 99352 Preface This manual provides the scientific and technical foundations for bioassay program design and interpretation, and for the assessment of occupational intakes and internal doses. The Hanford Internal Dosimetry Project Manual (PNNL-MA-552)(a) applies these foundations to define the recommended worker bioassay monitoring programs and internal dose assessment efforts at the Hanford Site. According to the DOE Internal Dosimetry Program Guide (DOE G 441.1-3, 03-17-99), a technical basis document should record the approach to evaluating internal doses from bioassay data, and where appropriate, from workplace monitoring data. It should also describe the physical and chemical characteristics of radioactive materials encountered in the workplace; methods for calculating internal doses and dose equivalents and the methods for documenting those calculations; dose evaluation quality assurance; recording and reporting practices for internal dosimetry; selection of workers for monitoring; and establishment of the type and frequency of measurements to be used. Furthermore, statistical methods for evaluating bioassay data, identifying bioassay results above environmental background values, using appropriate blanks, and analyzing trends should be described. This manual describes the basic methods and biokinetic models used for bioassay program design, interpretation, and internal dose assessment. These methods and models are combined with good practices and professional judgment to give the operational recommendations for routine and special bioassay monitoring contained in the Hanford Internal Dosimetry Project Manual (PNNL-MA-552). The actual selection of workers for monitoring and the characterization of the physical, chemical, and radiological properties of contaminants in the many Hanford facilities are the domain of the individual Hanford contractors. The recommendations in this manual are provided as guidance, not requirements, to personnel responsible for designing and operating bioassay monitoring programs and evaluating bioassay results. Commitments by contractors to use these recommendations may be found in the contractor radiation protection plans. This manual is on a 3-year revision schedule, however individual sections are revised as necessary, and upon revision, commence their own 3-year revision cycle. This manual is maintained by the Hanford Internal Dosimetry Program, operated by the Pacific Northwest National Laboratory’s (PNNL’s) Radiation and Health Technology group. The contact person for questions or comments regarding the content of this manual is Eugene H. Carbaugh at 376-6632. Available email address: [email protected] (a) Pacific Northwest National Laboratory (PNNL). Hanford Internal Dosimetry Project Manual. PNNL-MA-552, Richland, Washington. (Internal manual.) Available URL: http://www.pnl.gov/eshs/pub/pnnl552.html Issued: January 31, 2003 PNNL-MA-860 Preface Page iii Acronyms and Abbreviations ACGIH American Conference on Governmental Industrial Hygienists ALI annual limit on intake AMAD activity median aerodynamic diameter ANSI American National Standards Institute BEIR Biological Effects of Ionizing Radiation CEDE committed effective dose equivalent CINDY code for internal dosimetry CF commercial fuel CFR Code of Federal Regulations CL contract limit DAC derived air concentration DCL derived compliance level DCF dose conversion factor D&D decontamination and decommissioning DIL derived investigation level DL decision level DOE U.S. Department of Energy DRL dose reporting level DSL derived screening level DTPA diethylene triamine pentaacetic acid DU depleted uranium EDF Emergency Decontamination Facility EDTA ethylene diamine tetraacetic acid EPA U.S. Environmental Protection Agency FAO Food and Agriculture Organization FFTF Fast Flux Test Facility GI gastrointestinal HEHF Hanford Environmental Health Foundation HIDP Hanford Internal Dosimetry Program HPS Health Physics Society HTO tritiated water vapor or liquid IAEA International Atomic Energy Agency ICPMS inductively coupled plasma mass spectrometry Issued: January 31, 2003 PNNL-MA-860 Acronyms Supersedes: September 30, 2000 Page v ICRP International Commission on Radiological Protection IL investigation level IRF intake retention function IVRRF In Vivo Radioassay and Research Facility Lc critical level of detection Ld detection level LLD lower limit of detection MDA minimum detectable activity or amount MDD minimum detectable dose MDI minimum detectable intake MKIV Mark IV MPBB maximum permissible body burden NBS National Bureau of Standards NCRP National Council on Radiation Protection and Measurements NIOSH National Institute for Occupational Safety and Health NU natural uranium NWVP Nuclear Waste Vitrification Project OBT organically bound tritium ORNL Oak Ridge National Laboratory OSHA Occupational Safety and Health Administration PC personal computer PEL permissible exposure limit PFP Plutonium Finishing Plant PHS Public Health Services PNL Pacific Northwest Laboratory PNNL Pacific Northwest National Laboratory PUREX Plutonium-Uranium Extraction Plant (or process) RU recycled uranium SEE specific effective energy SI small intestine SL screening level STC special tritium compound STEL short-term exposure limit TLV threshold limit valve TPU total propagated uncertainty UNSCEAR United Nations Scientific Committee on the Effects of Atomic Radiation PNNL-MA-860 Acronyms Issued: January 31, 2003 Page vi Supersedes: September 30, 2000 USTUR United States Transuranium and Uranium Registries UO3 Uranium Oxide (Plant) VL verification level WESF Waste Encapsulation and Storage Facility WHO World Health Organization Issued: January 31, 2003 PNNL-MA-860 Acronyms Supersedes: September 30, 2000 Page vii Contents Preface .............................................................................................................................................. iii Acronyms and Abbreviations ............................................................................................................ v 1.0 Introduction................................................................................................................................. 1.1 1.1 Document Description....................................................................................................... 1.1 1.2 Document History.............................................................................................................. 1.2 1.3 References ......................................................................................................................... 1.4 2.0 General Methods for Internal Dosimetry.................................................................................... 2.1 2.1 Radiation Quality and Tissue Weighting Factors.............................................................. 2.1 2.2 Biokinetic Models.............................................................................................................. 2.2 2.3 Bioassay Measurements.................................................................................................... 2.3 2.4 Internal Dosimetry Assessments........................................................................................ 2.3 2.5 Organs or Tissues of Concern............................................................................................ 2.4 2.6 Particle Size ......................................................................................................................
Load more

Recommended publications
  • 1 RC-6 Internal Dosimetry the Science and Art of Internal Dose
    RC-6 Internal Dosimetry The science and art of internal dose assessment H. Doerfel a, A. Andrasi b, M. Bailey c, V. Berkovski d, E. Blanchardon e, C.-M. Castellani f, R. Cruz-Suarez g, G. Etherington c, C. Hurtgen h, B. LeGuen i, I. Malatova j, J. Marsh c, J. Stather c aIDEA System GmbH, Am Burgweg 4, 76227 Karlsruhe, Germany, [email protected] bKFKI Atomic Energy Research Institute, Budapest, Hungary cRadiation Protection Division, Health Protection Agency, Chilton, Didcot, UK dRadiation Protection Institute, Kiev, Ukraine eInstitut de Radioprotection et de Sûreté Nucleaire, Fontenay-aux-Roses, France fENEA Radiation Protection Institute, Bologna, Italia gInternational Atomic Energy Agency, Vienna, Austria hSCK•CEN Belgian Nuclear Research Centre, Mol, Belgium iElectricite de France, Saint-Denis, France jNRPI, Prague, Czech Republic 1 Abstract Doses from intakes of radionuclides cannot be measured but must be assessed from monitoring, such as whole body counting or urinary excretion measurements. Such assessments require application of a biokinetic model and estimation of the exposure time, material properties, etc. Because of the variety of parameters involved, the results of such assessments may vary over a wide range, according to the skill and the experience of the assessor. The refresher course gives an overview over the state of the art of the determination of internal dose. The first part of the course deals with the measuring techniques for individual incorporation monitoring i.e (i) direct measurement of activity in the whole body or organs, (ii) measurement of activity excreted with urine and faeces, and (iii) measurement of activity in the breathing zone or at the workplace, respectively.
    [Show full text]
  • Chapter 1.2: Transformation Kinetics
    Chapter 1: Radioactivity Chapter 1.2: Transformation Kinetics 200 NPRE 441, Principles of Radiation Protection Chapter 1: Radioactivity http://www.world‐nuclear.org/info/inf30.html 201 NPRE 441, Principles of Radiation Protection Chapter 1: Radioactivity Serial Transformation In many situations, the parent nuclides produce one or more radioactive offsprings in a chain. In such cases, it is important to consider the radioactivity from both the parent and the daughter nuclides as a function of time. • Due to their short half lives, 90Kr and 90Rb will be completely transformed, results in a rapid building up of 90Sr. • 90Y has a much shorter half‐life compared to 90Sr. After a certain period of time, the instantaneous amount of 90Sr transformed per unit time will be equal to that of 90Y. •Inthiscase,90Y is said to be in a secular equilibrium. 202 NPRE 441, Principles of Radiation Protection Chapter 1: Radioactivity Exponential DecayTransformation Kinetics • Different isotopes are characterized by their different rate of transformation (decay). • The activity of a pure radionuclide decreases exponentially with time. For a given sample, the number of decays within a unit time window around a given time t is a Poisson random variable, whose expectation is given by t Q Q0e •Thedecayconstant is the probability of a nucleus of the isotope undergoing a decay within a unit period of time. 203 NPRE 441, Principles of Radiation Protection Chapter 1: Radioactivity Why Exponential Decay? The decay rate, A, is given by Separate variables in above equation, we have The decay constant is the probability of a nucleus of the isotope undergoing a decay within a unit period of time.
    [Show full text]
  • Experimental Γ Ray Spectroscopy and Investigations of Environmental Radioactivity
    Experimental γ Ray Spectroscopy and Investigations of Environmental Radioactivity BY RANDOLPH S. PETERSON 216 α Po 84 10.64h. 212 Pb 1- 415 82 0- 239 β- 01- 0 60.6m 212 1+ 1630 Bi 2+ 1513 83 α β- 2+ 787 304ns 0+ 0 212 α Po 84 Experimental γ Ray Spectroscopy and Investigations of Environmental Radioactivity Randolph S. Peterson Physics Department The University of the South Sewanee, Tennessee Published by Spectrum Techniques All Rights Reserved Copyright 1996 TABLE OF CONTENTS Page Introduction ....................................................................................................................4 Basic Gamma Spectroscopy 1. Energy Calibration ................................................................................................... 7 2. Gamma Spectra from Common Commercial Sources ........................................ 10 3. Detector Energy Resolution .................................................................................. 12 Interaction of Radiation with Matter 4. Compton Scattering............................................................................................... 14 5. Pair Production and Annihilation ........................................................................ 17 6. Absorption of Gammas by Materials ..................................................................... 19 7. X Rays ..................................................................................................................... 21 Radioactive Decay 8. Multichannel Scaling and Half-life .....................................................................
    [Show full text]
  • Nuclide Safety Data Sheet Iron-59
    59 Nuclide Safety Data Sheet 59 Iron-59 Fe www.nchps.org Fe I. PHYSICAL DATA 1 Gammas/X-rays: 192 keV (3% abundance); 1099 keV (56%), 1292 keV (44%) Radiation: 1 Betas: 131 keV (1%), 273 keV (46%), 466 keV (53%) 2 Gamma Constant: 0.703 mR/hr per mCi @ 1.0 meter [1.789E-4 mSv/hr per MBq @ 1.0 meter] 1 Half-Life [T½] : Physical T½: 44.5 day 3 Biological T½: ~1.7 days (ingestion) ; much longer for small fraction Effective T½: ~1.7 days (varies; also small fraction retained much longer) Specific Activity: 4.97E5 Ci/g [1.84E15 Bq/g] max.1 II. RADIOLOGICAL DATA Radiotoxicity4: 1.8E-9 Sv/Bq (67 mrem/uCi) of 59Fe ingested [CEDE] 4.0E-9 Sv/Bq (150 mrem/uCi) of 59Fe inhaled [CEDE] Critical Organ: Spleen1, [blood] Intake Routes: Ingestion, inhalation, puncture, wound, skin contamination (absorption); Radiological Hazard: Internal Exposure; Contamination III. SHIELDING Half Value Layer [HVL] Tenth Value Layer [TVL] Lead [Pb] 15 mm (0.59 inches) 45 mm (1.8 inches) Steel 35 mm (1.4 inches) 91 mm (3.6 inches) The accessible dose rate should be background but must be < 2 mR/hr IV. DOSIMETRY MONITORING - Always wear radiation dosimetry monitoring badges [body & ring] whenever handling 59Fe V. DETECTION & MEASUREMENT Portable Survey Meters: Geiger-Mueller [e.g. PGM] to assess shielding effectiveness & contamination Wipe Test: Liquid Scintillation Counter, Gamma Counter VI. SPECIAL PRECAUTIONS • Avoid skin contamination [absorption], ingestion, inhalation, & injection [all routes of intake] • Use shielding (lead) to minimize exposure while handling of 59Fe • Use tools (e.g.
    [Show full text]
  • Forschungszentrum Karlsruhe Third European Intercomparison Exercise
    Forschungszentrum Karlsruhe Technik und Umwelt Wissenschaftliche Berichte FZKA 6457 Third European Intercomparison Exercise on Internal Dose Assessment Results of a Research Programme in the Framework of the EULEP/EURADOS Action Group “Derivation of Parameter Values for Application to the New Model of the Human Respiratory Tract for Occupational Exposure” 1997-1999 H. Doerfel, A. Andrasi 1), M. R. Bailey 2), A. Birchall 2), C.-M. Castellani 3), C. Hurtgen 4), N. Jarvis 2), L. Johansson 5), B. LeGuen 6), G. Tarroni 3) Hauptabteilung Sicherheit 1) AERI, Budapest, Hungary 2) NRPB, Chilton Didcot, United Kingdom 3) ENEA, Bologna, Italy 4) CEN/SCK, Mol, Belgium 5) University of Umea, Umea, Sweden 6) EDF-GDF, Saint Denis Cedex, France Forschungszentrum Karlsruhe GmbH, Karlsruhe 2000 Abstract The EULEP/EURADOS Action Group „Derivation of Parameter Values for Application to the New Model of the Human Respiratory Tract for Occupational Exposure“ has initiated a new intercomparison exercise on internal dose assessment. During the last few years the ICRP has developed a new generation of more realistic internal dosimetry models, including the Human Respiratory Tract Model (ICRP Publication 66) and recycling systemic models for actinides. These models have been used to calculate dose coefficients, which have been adopted in the revised EURATOM Directive. This recent intercomparison exercise gave special consideration to the effects of the new models and the choice of input parameters on the assessment of internal doses from monitoring results. It also took into account some aspects which have not been considered in previous exercises, such as air monitoring, natural radionuclides, exposure of the public, artificially created cases and artificially reduced information.
    [Show full text]
  • Medical Management of Persons Internally Contaminated with Radionuclides in a Nuclear Or Radiological Emergency
    CONTAMINATION EPR-INTERNAL AND RESPONSE PREPAREDNESS EMERGENCY EPR-INTERNAL EPR-INTERNAL CONTAMINATION CONTAMINATION 2018 2018 2018 Medical Management of Persons Internally Contaminated with Radionuclides in a Nuclear or Radiological Emergency Contaminatedin aNuclear with Radionuclides Internally of Persons Management Medical Medical Management of Persons Internally Contaminated with Radionuclides in a Nuclear or Radiological Emergency A Manual for Medical Personnel Jointly sponsored by the Endorsed by AMERICAN SOCIETY FOR RADIATION ONCOLOGY INTERNATIONAL ATOMIC ENERGY AGENCY V I E N N A ISSN 2518–685X @ IAEA SAFETY STANDARDS AND RELATED PUBLICATIONS IAEA SAFETY STANDARDS Under the terms of Article III of its Statute, the IAEA is authorized to establish or adopt standards of safety for protection of health and minimization of danger to life and property, and to provide for the application of these standards. The publications by means of which the IAEA establishes standards are issued in the IAEA Safety Standards Series. This series covers nuclear safety, radiation safety, transport safety and waste safety. The publication categories in the series are Safety Fundamentals, Safety Requirements and Safety Guides. Information on the IAEA’s safety standards programme is available on the IAEA Internet site http://www-ns.iaea.org/standards/ The site provides the texts in English of published and draft safety standards. The texts of safety standards issued in Arabic, Chinese, French, Russian and Spanish, the IAEA Safety Glossary and a status report for safety standards under development are also available. For further information, please contact the IAEA at: Vienna International Centre, PO Box 100, 1400 Vienna, Austria. All users of IAEA safety standards are invited to inform the IAEA of experience in their use (e.g.
    [Show full text]
  • Radiation Quantities and Units Definitions
    Radiation Quantities and Units Definitions The quantities and units of radiation dose are inherently more complex than those used in toxicology or pharmacology, and additional complexity has resulted from several changes required by evolving concepts in radiation dosimetry. The first widely used physical quantity of radiation was “exposure,” related to the ability of x or gamma radiation to ionize air; its unit was the roentgen (R). Exposure was limited to photon radiation with energy less than 2.5 MeV. The quantity “absorbed dose” (D) was introduced because it was applicable to all forms of ionizing radiation and absorbing materials. Absorbed dose is energy deposited per unit mass, and its original unit was the rep (roentgen equivalent-physical); 1 rep equaled 93 ergs per g (0.0093 J per kg) of absorbing material. The rep was replaced with the rad (radiation absorbed dose); 1 rad equaled 100 ergs per g (0.01 J per kg). The “dose equivalent” (H) and its unit, the rem (roentgen equivalent-man), were introduced to account for the different biologic effects of the same absorbed dose from different types of radiation; H is the product of D, Q, and N at a point of interest in tissue, where D is absorbed dose, Q is the quality factor, and N is the product of any other modifying factors. The “effective dose equivalent” was introduced to include the different sensitivities of individual tissues and organs, which are important for internal dosimetry: its unit is the same as the unit of “dose equivalent.” In the 1990 recommendations of the International Commission on Radiological Protection (ICRP 1991), the use of N was dropped and the radiation weighting factor (WR) was substituted for Q.
    [Show full text]
  • Perspective on Internal Contamination and Dose
    Perspective on Internal Contamination and Dose Hanford Internal Dosimetry Program 1 What is meant by contamination and dose? Contamination: the unwanted presence of radioactive material. Dose: energy deposited in the body by radioactive decay of contamination 2 External and Internal Sources External exposure: Route of intake: Route of intake: no intake inhalation skin absorption Route of intake: Route of intake: wound exposure ingestion 3 Measuring External Dose Dosimeters measure dose from external sources. Left: Hanford Left: Hanford combination standard neutron dosimeter dosimeter Below: Hanford extremity dosimeter Dose from internal contamination (within the body) cannot be measured by dosimeters. 4 External Dose vs. Internal Dose External Dose Internal Dose • Generally, easy to measure with • Requires determination from a dosimeter bioassay measurements of • Usually reported as a “whole material in the body or excreted body” or “effective” dose from the body • Type of bioassay depends on radioactive material • Optimum type of bioassay depends on radioactive material and time since intake occurred 5 Bioassay Methods There are several bioassay methods used to determine intake and internal dose: • Whole body exam/count Left: a whole body • Chest count count and lung count being taken • Wound count • Urine/fecal sample analysis Left: the in-home kit for collecting urine or fecal samples for bioassay 6 How Critical is Time to Bioassay? Don’t sample too soon… but don’t wait too long • The material may not be present in the bladder or bowel if the sample is taken too soon. • Dose detection capability varies with time after intake. Getting a bioassay at the right time can provide a more accurate analysis.
    [Show full text]
  • External and Internal Dosimetry
    Chapter 7 External and Internal Dosimetry H-117 – Introductory Health Physics Slide 1 Objectives ¾ Discuss factors influencing external and internal doses ¾ Define terms used in external dosimetry ¾ Discuss external dosimeters such as TLDs, film badges, OSL dosimeters, pocket chambers, and electronic dosimetry H-117 – Introductory Health Physics Slide 2 Objectives ¾ Define terms used in internal dosimetry ¾ Discuss dose units and limits ¾ Define the ALI, DAC and DAC-hr ¾ Discuss radiation signs and postings H-117 – Introductory Health Physics Slide 3 Objectives ¾ Discuss types of bioassays ¾ Describe internal dose measuring equipment and facilities ¾ Discuss principles of internal dose calculation and work sample problems H-117 – Introductory Health Physics Slide 4 External Dosimetry H-117 – Introductory Health Physics Slide 5 External Dosimetry Gamma, beta or neutron radiation emitted by radioactive material outside the body irradiates the skin, lens of the eye, extremities & the whole body (i.e. internal organs) H-117 – Introductory Health Physics Slide 6 External Dosimetry (cont.) ¾ Alpha particles cannot penetrate the dead layer of skin (0.007 cm) ¾ Beta particles are primarily a skin hazard. However, energetic betas can penetrate the lens of an eye (0.3 cm) and deeper tissue (1 cm) ¾ Beta sources can produce more penetrating radiation through bremsstrahlung ¾ Primary sources of external exposure are photons and neutrons ¾ External dose must be measured by means of appropriate dosimeters H-117 – Introductory Health Physics Slide 7
    [Show full text]
  • Internal Dosimetry Co-Exposure Data for the Savannah River Site
    Page 1 of 287 DOE Review Release 09/04/2020 ORAUT-OTIB-0081 Rev. 05 Internal Dosimetry Co-Exposure Data for the Effective Date: 09/01/2020 Savannah River Site Supersedes: Revision 04 Subject Expert(s): Matthew G. Arno, James M. Mahathy, and Nancy Chalmers Document Owner Signature on File Approval Date: 08/24/2020 Approval: Matthew G. Arno, Document Owner Concurrence: Signature on File Concurrence Date: 08/24/2020 John M. Byrne, Objective 1 Manager Concurrence: Signature on File Concurrence Date: 08/24/2020 Scott R. Siebert, Objective 3 Manager Concurrence: Vickie S. Short Signature on File for Concurrence Date: 08/24/2020 Kate Kimpan, Project Director Approval: Signature on File Approval Date: 08/25/2020 Timothy D. Taulbee, Associate Director for Science FOR DOCUMENTS MARKED AS A TOTAL REWRITE, REVISION, OR PAGE CHANGE, REPLACE THE PRIOR REVISION AND DISCARD / DESTROY ALL COPIES OF THE PRIOR REVISION. New Total Rewrite Revision Page Change Document No. ORAUT-OTIB-0081 Revision No. 05 Effective Date: 09/01/2020 Page 2 of 287 PUBLICATION RECORD EFFECTIVE REVISION DATE NUMBER DESCRIPTION 02/08/2013 00 New technical information bulletin to provide internal coworker data for the Savannah River Site. Incorporates formal internal and NIOSH review comments. Training required: As determined by the Objective Manager. Initiated by Matthew Arno. 04/01/2013 01 Revision initiated to correct the values provided in Tables 5-6, Type S uranium intake rates for 1968 through 2007, 5-10, changed end date from 2006 to 2007, A-3, plutonium bioassay data for 1955 through 2007, and A-8, neptunium bioassay data for 1991 through 2007.
    [Show full text]
  • General Chapter <821> Radioactivity
    BRIEFING 821 Radioactivity, USP 38 page 616. This chapter was introduced in its current form in 1975 and has not undergone any major revision since its first publication. Currently, ⟨the chapter⟩ contains definitions, special considerations, and procedures with respect to the monographs for radiopharmaceuticals (radioactive drugs). The majority of this chapter is informational. USP has launched an initiative to minimize nonprocedural information in general chapters with numbers below 1000. The USP Council of Experts believes that 821 should be revised as part of this initiative. To achieve this objective, several members of the USP Council of Experts jointly published a Stimuli article in PF 38(4) [July–Aug.⟨ 2012],⟩ Revision of General Chapter Radioactivity 821 . The objectives of this Stimuli article were threefold: (1) provide background information about the need for the proposed revision, (2) initiate discussion about this topic, and⟨ (3)⟩ solicit public comments for review and discussion by the relevant Expert Committee and Expert Panel members and USP staff. The current chapter is divided into two major sections, General Considerations and Identification and Assay of Radionuclides, both of which contain several subsections with information about aspects of radioactivity. Because of the nature of the information presented in these subsections, these can be moved to the proposed Radioactivity— Theory and Practice 1821 . The Terms and Definitions section is now listed as Glossary and has been revised to reflect current practices. The revised chapter will contain procedures and⟨ information⟩ about instrumentation used in the identification and assay of the radionuclides, along with appropriate information about calibration and maintenance of instrumentation.
    [Show full text]
  • Internal Dosimetry Hazard and Risk Assessments: Methods and Applications G
    DOSIMETRY AND INSTRUMENTATION INTERNAL DOSIMETRY HAZARD AND RISK ASSESSMENTS: METHODS AND APPLICATIONS G. A. Roberts RWE NUKEM Limited, Didcot, UK ABSTRACT Routine internal dose exposures are typically (in the UK nuclear industry) less than external dose exposures: however, the costs of internal dosimetry monitoring programmes can be significantly greater than those for external dosimetry. For this reason decisions on when to apply routine monitoring programmes, and the nature of these programmes, can be more critical than for external dosimetry programmes. This paper describes various methods for performing hazard and risk assessments which are being developed by RWE NUKEM Limited Approved Dosimetry Services to provide an indication when routine internal dosimetry monitoring should be considered. INTRODUCTION The estimation of internal dose needs to be inferred from the measurement of activity in the individual (by in-vivo or in-vitro methods) or in the workplace environment. A variety of monitoring methods are available for making these measurements [1]. A review of the current monitoring practices within European Union countries was included within the OMINEX project (Optimisation of Monitoring for Internal Exposure) [2] and are summarised in Table 1. Type of Total Monitoring method Monitoring operation number In vivo Bioassay SAS/PAS Routine Special Both Nuclear power 34 33 15 7 8 4 27 plant Reprocessing 2 2 2 - - - 1 Fuel 7 6 6 2 3 2 5 fabrication Decommiss- 6 5 6 1 2 2 5 ioning Research 19 17 12 5 3 5 16 Non-nuclear 3 3 3 2 2 2 2 SAS – static air sampling PAS – personal air sampling Table 1: Number of organisations using each monitoring method for routine or special monitoring, classified by type of operation.
    [Show full text]